Literature DB >> 8013270

Single dose intravenous pharmacokinetics of fluconazole in infants.

I Krzeska1, R A Yeates, G Pfaff.   

Abstract

The present report contains an open, non-comparative study of the plasma pharmacokinetics of a single intravenous dose (3 mg/kg) of the antimycotic agent fluconazole in infants, aged between 9 days and 4.4 months (n = 14), who were either suffering from or regarded as being susceptible to fungal infection. The mean volume of distribution was calculated as 1.17 l/kg, with a range between 0.76 and 2.60 l/kg; the comparable value for adult volunteers was 0.65 +/- 0.08 l/kg (1). The mean total clearance was calculated as 0.63 +/- 0.06 ml/min x kg; the comparable value for adult volunteers was 0.25 +/- 0.04 ml/min x kg (1). The terminal half-life of elimination was calculated as 22.5 +/- 2.2 h; the comparable value for adult volunteers was 30.2 +/- 3.8 h (1). It is suggested that this difference was caused by the countervailing effects of the changes with age in clearance and in volume of distribution.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8013270

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  6 in total

1.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

2.  Pharmacokinetics of oral fluconazole when used for prophylaxis in bone marrow transplant recipients.

Authors:  A El-Yazigi; M Ellis; P Ernst; D Spence; R Hussain; F J Baillie
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 3.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Developmental changes of fluconazole clearance in neonates and infants in relation to ontogeny of glomerular filtration rate: literature review and data analysis.

Authors:  Kazutoshi Murakoso; Ryoichi Minagawa; Hirotoshi Echizen
Journal:  J Pharm Health Care Sci       Date:  2018-03-20

Review 5.  Clinical Pharmacokinetics of Triazoles in Pediatric Patients.

Authors:  Didi Bury; Wim J E Tissing; Eline W Muilwijk; Tom F W Wolfs; Roger J Brüggemann
Journal:  Clin Pharmacokinet       Date:  2021-05-18       Impact factor: 5.577

Review 6.  Safety of fluconazole in paediatrics: a systematic review.

Authors:  Oluwaseun Egunsola; Abiodun Adefurin; Apostolos Fakis; Evelyne Jacqz-Aigrain; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2013-01-17       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.